Hunan Er Kang Pharmaceutical Cash Flow Reinvestment Rate
Hunan Er Kang Pharmaceutical cash flow reinvestment rate. Hunan Er Kang Pharmaceutical (300267) has a Cash Flow Reinvestment Rate of 0.46x as of June 2023, reinvesting CN¥80.56 Million (capex CN¥45.68 Million plus investments CN¥34.88 Million) from operating cash flow of CN¥174.55 Million. Explore 300267 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hunan Er Kang Pharmaceutical (2008–2024)
Cash flow reinvestment rate of Hunan Er Kang Pharmaceutical from 2008 to 2024. Historical reinvestment intensity for Hunan Er Kang Pharmaceutical across 17 annual periods. Explore capital reinvestment ratio of Hunan Er Kang Pharmaceutical to see what proportion of operating cash flow is directed to capital expenditures.
Hunan Er Kang Pharmaceutical Cash Flow Reinvestment Rate by Year (2008–2024)
Hunan Er Kang Pharmaceutical cash flow reinvestment rate by year from 2008 to 2024. Year-by-year capital reinvestment analysis for Hunan Er Kang Pharmaceutical. For the full cash flow conversion analysis, see Hunan Er Kang Pharmaceutical operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.11x | CN¥517.75 Million | CN¥166.69 Million | CN¥195.60 Million | ▲ +34.4% |
| 2023 | 2.31x | CN¥343.11 Million | CN¥148.42 Million | CN¥238.19 Million | ▲ +137.5% |
| 2022 | 0.97x | CN¥273.49 Million | CN¥281.02 Million | CN¥173.49 Million | ▼ -87.2% |
| 2021 | 7.60x | CN¥704.27 Million | CN¥92.68 Million | CN¥349.33 Million | ▲ +27.7% |
| 2020 | 5.95x | CN¥1.06 Billion | CN¥178.53 Million | CN¥605.89 Million | ▲ +431.5% |
| 2019 | 1.12x | CN¥498.88 Million | CN¥445.82 Million | CN¥364.21 Million | ▼ -40.1% |
| 2018 | 1.87x | CN¥231.39 Million | CN¥123.89 Million | CN¥96.72 Million | ▲ +269.0% |
| 2017 | 0.51x | CN¥348.81 Million | CN¥689.11 Million | CN¥258.92 Million | ▼ -80.8% |
| 2016 | 2.64x | CN¥1.29 Billion | CN¥486.50 Million | CN¥1.15 Billion | ▲ +140.4% |
| 2015 | 1.10x | CN¥570.53 Million | CN¥518.96 Million | CN¥570.53 Million | ▼ -63.4% |
| 2014 | 3.01x | CN¥527.42 Million | CN¥175.38 Million | CN¥527.42 Million | ▲ +156.9% |
| 2013 | 1.17x | CN¥203.98 Million | CN¥174.22 Million | CN¥203.98 Million | ▼ -57.5% |
| 2012 | 2.75x | CN¥231.28 Million | CN¥84.02 Million | CN¥231.28 Million | ▲ +375.1% |
| 2011 | 0.58x | CN¥43.87 Million | CN¥75.72 Million | CN¥43.87 Million | ▼ -62.2% |
| 2010 | 1.53x | CN¥65.05 Million | CN¥42.47 Million | CN¥65.05 Million | ▼ -20.6% |
| 2009 | 1.93x | CN¥19.64 Million | CN¥10.18 Million | CN¥19.64 Million | ▼ -96.8% |
| 2008 | 59.81x | CN¥12.62 Million | CN¥211.00K | CN¥12.62 Million | — |